Wells Fargo & Company Avanos Medical, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 114,537 shares of AVNS stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,537

Previous 104,830 9.26%

Holding current value

$1.41 Million

Previous $1.67 Million 1.62%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$13.95 - $17.45 $135,412 - $169,387	9,707 Added 9.26%	114,537 $1.64 Million
Q4 2024 Feb 12, 2025	BUY	$15.58 - $23.61 $262,803 - $398,253	16,868 Added 19.18%	104,830 $1.67 Million
Q3 2024 Nov 13, 2024	BUY	$19.21 - $24.69 $6,204 - $7,974	323 Added 0.37%	87,962 $2.11 Million
Q2 2024 Aug 13, 2024	BUY	$17.85 - $20.42 $45,124 - $51,621	2,528 Added 2.97%	87,639 $1.75 Million
Q1 2024 May 10, 2024	BUY	$17.97 - $22.68 $169,762 - $214,257	9,447 Added 12.49%	85,111 $1.69 Million
Q4 2023 Feb 09, 2024	SELL	$17.64 - $22.99 $35,738 - $46,577	-2,026 Reduced 2.61%	75,664 $1.7 Million
Q3 2023 Nov 13, 2023	SELL	$19.93 - $26.31 $189,474 - $250,129	-9,507 Reduced 10.9%	77,690 $1.57 Million
Q2 2023 Aug 15, 2023	BUY	$22.53 - $30.98 $468,488 - $644,198	20,794 Added 31.31%	87,197 $2.23 Million
Q1 2023 May 12, 2023	BUY	$26.92 - $31.75 $393,355 - $463,931	14,612 Added 28.21%	66,403 $1.97 Million
Q4 2022 Feb 13, 2023	SELL	$19.88 - $27.37 $165,998 - $228,539	-8,350 Reduced 13.88%	51,791 $1.4 Million
Q3 2022 Nov 14, 2022	SELL	$21.56 - $29.59 $52,196 - $71,637	-2,421 Reduced 3.87%	60,141 $1.31 Million
Q2 2022 Aug 12, 2022	SELL	$24.87 - $34.68 $951,103 - $1.33 Million	-38,243 Reduced 37.94%	62,562 $1.71 Million
Q1 2022 May 16, 2022	SELL	$28.87 - $35.77 $291,413 - $361,062	-10,094 Reduced 9.1%	100,805 $3.38 Million
Q4 2021 Feb 14, 2022	SELL	$29.25 - $36.02 $277,231 - $341,397	-9,478 Reduced 7.87%	110,899 $3.85 Million
Q3 2021 Nov 15, 2021	BUY	$31.2 - $38.5 $780,093 - $962,615	25,003 Added 26.22%	120,377 $3.76 Million
Q2 2021 Aug 16, 2021	SELL	$36.37 - $45.72 $340,932 - $428,579	-9,374 Reduced 8.95%	95,374 $3.47 Million
Q1 2021 May 13, 2021	SELL	$43.5 - $53.4 $1.3 Million - $1.6 Million	-29,929 Reduced 22.22%	104,748 $4.58 Million
Q4 2020 Feb 09, 2021	SELL	$33.15 - $49.5 $219,353 - $327,541	-6,617 Reduced 4.68%	134,677 $6.18 Million
Q3 2020 Nov 05, 2020	SELL	$28.67 - $34.32 $176,521 - $211,308	-6,157 Reduced 4.18%	141,294 $4.69 Million
Q2 2020 Aug 13, 2020	SELL	$23.48 - $33.86 $11.1 Million - $16 Million	-471,364 Reduced 76.17%	147,451 $4.33 Million
Q1 2020 May 14, 2020	BUY	$20.64 - $34.41 $12.8 Million - $21.3 Million	618,815 New	618,815 $16.7 Million

Others Institutions Holding AVNS

# of Institutions

298

Shares Held

43.3M

Call Options Held

3.5K

Put Options Held

13.2K

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $571M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Avanos Medical, Inc. Transaction History